ReviewEuropean journal of pediatrics2026
Utilization of integrated lung ultrasound and targeted neonatal echocardiography in preterm infant follow-up: is it feasible? Assessing value and practical challenges.
Review in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung ultrasound (LUS) and targeted neonatal echocardiography (TNE) are employed in some neonatal intensive care units throughout the hospital stay to monitor heart- and lung-related morbidities. However, preterm infants are at risk of increased rates of respiratory and cardiovascular morbidities across their lifespan. This commentary aims to define the utility of long-term TNE and LUS follow-up and to assess the challenges of incorporating these techniques into long-term practice. The cardiovascular phenotype of bronchopulmonary dysplasia (BPD) includes diverse cardiac and extracardiac anomalies. Many of these arise during hospitalization and can be detected on a multiparametric echocardiography examination. Nonetheless, several complications of prematurity related to pulmonary vascular disease arise after discharge, notably acute and chronic pulmonary hypertension and pulmonary vein stenosis. Similarly, LUS facilitates the diagnosis and prediction of several respiratory conditions affecting preterm infants during hospitalization, including respiratory distress syndrome and BPD. Limited data exist on LUS evolution after discharge. Multiple studies demonstrated that TNE significantly improves clinical and therapeutic outcomes in critically ill neonates, while evidence supporting LUS utility, though limited, continues to accumulate. Implementation of both LUS and TNE in preterm follow-up is challenged by limitations in training, resources, and institutional support.
conclusionAvailable evidence supports continuous ultrasound cardiopulmonary monitoring from birth through hospital discharge and into long-term follow-up. Neonatologists should look beyond immediate perinatal complications, as cardiorespiratory morbidities may remain subclinical yet emerge months to years later. Their unique integrated assessment of the cardiopulmonary system, coupled with safe and accessible tools, supports post-discharge TNE-LUS implementation without substantial barriers. WHAT IS KNOWN: • LUS and TNE are typically utilized during the admission period, a role that is well-defined and extensively documented in the literature. • After discharge, echocardiography provides comprehensive longitudinal data, whereas LUS has been poorly investigated. WHAT IS NEW: • The utilization of LUS and integrated TNE-LUS after discharge represents a significant research gap and a field of considerable potential utility in the long-term management of preterm infants. • Given their safety profile and accessibility, no substantial barriers preclude their post-discharge implementation.
Indexed as
Identifiers
41569467What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.